At Mersana, we have a passion for advancing therapies to make a significant impact in the lives of people living with cancer.
Mersana Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel antibody-drug conjugates (ADCs) and driven by the knowledge that patients are waiting for new treatment options. The company has developed proprietary cytotoxic (Dolasynthen) and immunostimulatory (Immunosynthen) ADC platforms that are generating a pipeline of wholly-owned and partnered product candidates with the potential to treat a range of cancers. Its pipeline includes XMT-1660, a Dolasynthen ADC targeting B7-H4, and XMT-2056, an Immunosynthen ADC targeting a novel epitope of human epidermal growth factor receptor 2 (HER2).
Company Details
- Employees
- 128
- Founded
- -
- Address
- 840 Memorial Drive, Cambridge,ma 02139,united States
- Phone
- 617-498-0020
- in****@****ana.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- mersana.com
- HQ
- Cambridge, MA
Mersana Therapeutics Questions
Mersana Therapeutics's helpline number is 617-498-0020
Mersana Therapeutics's website is mersana.com
Mersana Therapeutics's LinkedIn profile is https://www.linkedin.com/company/mersana-therapeutics
Mersana Therapeutics has
128 employees.
View email and phone details for 128
employees at Mersana Therapeutics.
Mersana Therapeutics's industry is
Biotechnology Research
Mersana Therapeutics's top competitors are
Vertex Pharmaceuticals,
Tessera Therapeutics,
Sarepta Therapeutics,
Arrakis Therapeutics,
Beam Therapeutics,
Dragonfly Therapeutics, Inc.,
Immunogen, Inc.,
Intellia Therapeutics, Inc.,
Skyhawk Therapeutics,
Kymera Therapeutics.
Mersana Therapeutics's support email address is info@mersana.com
Mersana Therapeutics's categories are Biotechnology Research
Mersana Therapeutics's founding year is 2001
